FDA Approves Weekly Basal Insulin for Adults With Type 2 Diabetes
The US Food and Drug Administration (FDA) approved insulin icodec-abae, marketed as Awiqli, making it the first once-weekly basal insulin treatment option for adults with type 2 diabetes.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.